EGenesis Funding & Investors
Cambridge, MA
eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells.
egenesisbio.comTotal Amount Raised: $456,000,000
EGenesis' Investors
EGenesis Funding Rounds
Series D
$191,000,000
Series D Investors
Lux CapitalFarallon Capital ManagementAlta PartnersArch Venture PartnersKhosla VenturesLeaps by BayerNatco PharmaDaVitaFresenius Medical Care North AmericaParkwoodEisai InnovationSeries C
$125,000,000
Series C Investors
Irving InvestorsLifeSci Venture PartnersMonashee Investment ManagementOUP (Osage University Partners)Farallon Capital ManagementAltium CapitalSamsara BioCapitalSymBiosisPolaris PartnersHBM Healthcare InvestmentsFresenius Medical Care North AmericaLeaps by BayerKhosla VenturesWellington PartnersCatalio Capital ManagementArch Venture PartnersInvus GroupAlta PartnersSeries B
$100,000,000
Series B Investors
Fresenius Medical Care North AmericaKhosla VenturesBiomatics Capital PartnersWellington PartnersLeaps by BayerAlta PartnersArch Venture PartnersSeries A
$38,000,000
Series A Investors
Arch Venture PartnersBiomatics Capital PartnersKhosla VenturesAlta PartnersAlexandria Real Estate EquitiesHeritage Provider NetworkBerggruen HoldingsUprisingFan VenturesJDRF T1D FundE Squared Capital ManagementConvertible Note
$2,000,000
Funding info provided by Diffbot.